Literature DB >> 32841316

Concomitant Marked Decline in Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Other Respiratory Viruses Among Symptomatic Patients Following Public Health Interventions in Australia: Data from St Vincent's Hospital and Associated Screening Clinics, Sydney, NSW.

Deborah Marriott1, Rohan Beresford2, Feras Mirdad1, Damien Stark1, Allan Glanville1, Scott Chapman1, Jock Harkness1, Gregory J Dore1,3, David Andresen1, Gail V Matthews1,3.   

Abstract

Our Australian hospital tested almost 22 000 symptomatic people over 11 weeks for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a multiplex polymerase chain reaction (PCR) assay. Following travel bans and physical distancing, SARS-CoV-2 and other respiratory viruses diagnoses fell dramatically. Increasing rhinovirus diagnoses as social control measures were relaxed may indirectly indicate an elevated risk of coronavirus disease 2019 (COVID-19) resurgence.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; SARS CoV-2; influenza; public health; screening

Mesh:

Year:  2021        PMID: 32841316      PMCID: PMC7499558          DOI: 10.1093/cid/ciaa1256

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  11 in total

1.  Investigating the human rhinovirus co-infection in patients with asthma exacerbations and COVID-19.

Authors:  Abdullah Al-Dulaimi; Ahmad R Alsayed; Mohammed Al Maqbali; Malek Zihlif
Journal:  Pharm Pract (Granada)       Date:  2022-05-02

2.  Impact of rhinovirus on hospitalization during the COVID-19 pandemic: A prospective cohort study.

Authors:  Marcelo Comerlato Scotta; Luciane Beatriz Kern; Márcia Polese-Bonatto; Thais Raupp Azevedo; Fernanda Hammes Varela; Gabriela Oliveira Zavaglia; Ingrid Rodrigues Fernandes; Caroline Nespolo de David; Tiago Fazolo; Marcela Santos Corrêa da Costa; Felipe Cotrim de Carvalho; Ivaine Tais Sauthier Sartor; Alexandre Prehn Zavascki; Renato T Stein
Journal:  J Clin Virol       Date:  2022-06-07       Impact factor: 14.481

3.  Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.

Authors:  Rosalía De la Puerta; Juan Montoro; Carla Aznar; Ignacio Lorenzo; Eva María González-Barberá; Aitana Balaguer-Roselló; Manuel Guerreiro; Lara Domínguez; Miguel Salavert; Cristóbal Aguilar; Javier de la Rubia; Jaime Sanz; María Dolores Gómez; José Luis Piñana
Journal:  Bone Marrow Transplant       Date:  2021-05-04       Impact factor: 5.483

4.  Interrupted time-series analysis showed unintended consequences of non-pharmaceutical interventions on pediatric hospital admissions.

Authors:  Hannah C Moore; Huong Le; Ariel Mace; Christopher C Blyth; Daniel Yeoh; David Foley; Andrew Martin
Journal:  J Clin Epidemiol       Date:  2021-11-18       Impact factor: 7.407

5.  Decline of Influenza and Respiratory Viruses With COVID-19 Public Health Measures: Alberta, Canada.

Authors:  Alexander Doroshenko; Nelson Lee; Clayton MacDonald; Nathan Zelyas; Leyla Asadi; Jamil N Kanji
Journal:  Mayo Clin Proc       Date:  2021-09-20       Impact factor: 7.616

6.  Evaluation of Four Fully Integrated Molecular Assays for the Detection of Respiratory Viruses during the Co-Circulation of SARS-CoV-2, Influenza and RSV.

Authors:  Eric Farfour; Thomas Yung; Robin Baudoin; Marc Vasse
Journal:  J Clin Med       Date:  2022-07-06       Impact factor: 4.964

7.  Respiratory pathogens during the COVID-19 pandemic: Alterations in detection and seasonality in Nashville, Tennessee.

Authors:  Zaid Haddadin; Andrew J Spieker; Herdi Rahman; Danielle A Rankin; Rana Talj; Ahmad Yanis; Justin Z Amarin; Jonathan Schmitz; James Chappell; Natasha B Halasa
Journal:  PLoS One       Date:  2022-08-03       Impact factor: 3.752

8.  Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data.

Authors:  Djin-Ye Oh; Silke Buda; Barbara Biere; Janine Reiche; Frank Schlosser; Susanne Duwe; Marianne Wedde; Max von Kleist; Martin Mielke; Thorsten Wolff; Ralf Dürrwald
Journal:  Lancet Reg Health Eur       Date:  2021-06-07

9.  Rhinovirus prevalence as indicator for efficacy of measures against SARS-CoV-2.

Authors:  Simo Kitanovski; Gibran Horemheb-Rubio; Ortwin Adams; Barbara Gärtner; Thomas Lengauer; Daniel Hoffmann; Rolf Kaiser
Journal:  BMC Public Health       Date:  2021-06-21       Impact factor: 3.295

10.  Preterm Infant Outcomes Following COVID-19 Lockdowns in Melbourne, Australia.

Authors:  Brendan Mulcahy; Daniel L Rolnik; Alexia Matheson; Yizhen Liu; Kirsten R Palmer; Ben W Mol; Atul Malhotra
Journal:  Children (Basel)       Date:  2021-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.